Chinese Journal of Pharmacovigilance ›› 2018, Vol. 15 ›› Issue (9): 574-574.
Previous Articles Next Articles
CHEN Huanlei, ZHAO Xiaoyan, DONG Yang, WANG Zhenhua*
Received:2018-11-02
Revised:2018-11-02
Online:2018-09-20
Published:2018-11-02
CLC Number:
CHEN Huanlei, ZHAO Xiaoyan, DONG Yang, WANG Zhenhua. One Case of Rhabdomyolysis Induced by Rosuvastatin Calcium Combined with Colchicine Tablets[J]. Chinese Journal of Pharmacovigilance, 2018, 15(9): 574-574.
| [1] 章梅华, 卢晓阳, 杨志海,等. 横纹肌溶解症及其发病机制研究进展[J].中华急诊医学杂志, 2010, 19( 11) : 1226-1228. [2] Rasche-Sch rmann C C, Picksak G, Stichtenoth D O. Creatine kinase increase under simvastatin-therapeutic consequences?[J].Med Monatsschr Pharm, 2008, 31(1): 25-27. [3] Khan F Y,Ibrahim W.Rosuvastatin induced rhabdomyolysis in a low risk patient: a case report and review of the literature[J].Curr Clin Pharmacol,2009,4( 1) : 1-3. [4] 宋树斌, 冯慧琴, 谢洪,等.秋水仙碱致急性横纹肌溶解症1例[J]. 医药导报, 2012, 31(12): 1656-1657. [5] 李平,王敏,陈岚,等.辛伐他汀致横纹肌溶解不良反应1例[J]. 中国药物警戒,2013,10(8):512. [6] Tufan A, Dede D S, Cavus S, et al.Rhabdomyolysis in a patient treated with colchicine and atorvastatin[J]. Ann Pharmacother, 2006, 40(8): 7-8. [7] 张亮,张向荣,周秋云,等.左氧氟沙星注射液致肌酸激酶升高1例[J]. 中国药物警戒,2018,15(1):57-58. [8] Radcliffe K A, Campbell W W.Statin myopathy[J].Curr Neurol Neurosci Rep,2008, 8(1) : 66-72. [9] 岳慧杰, 宋小骏, 冷静,等. 瑞舒伐他汀致横纹肌溶解症[J]. 药物不良反应杂志, 2011, 13(6): 389-390. [10] 郑超群, 阮 , 黄燕萍. 瑞舒伐他汀致横纹肌溶解症1例[J]. 中国临床新医学, 2013, 6(8): 803-805. [11] 梁莹,王妍春. 秋水仙碱致横纹肌溶解综合征并急性肾衰竭1例[J]. 实用医学杂志,2013,29(6):1034. |
| [1] | SUN Qiyue, ZHAO Ronghua, GUO Shanshan, BAO Lei, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing. Multiple pharmacological effects of Lingyang Ganmao Oral Liquid [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 127-131. |
| [2] | ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, TAO Xiali, ZHANG Jingsheng, PANG Bo, XU Yingli, CAO Shan, LI Shuran, GUO Shanshan, WANG Daohan, CUI Xiaolan. Mechanisms of Gegen Tang granules against viral pneumonia in mice based on immune regulation [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 132-136. |
| [3] | BAO Lei, GENG Zihan, LI Shuran, JI Zuen, ZHAO Ronghua, SUN Jing, GUO Shanshan, CUI Xiaolan. The critical role of TRP channels in the progression of viral pneumonia [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 137-140. |
| [4] | JIA Jinsheng, LIU Hongliang, WANG Qing, HOU Yongfang, LI Xinling. Evaluation of the relevance of adverse drug reaction based on ERNIE-DPCNN [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 163-166. |
| [5] | LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo. Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180. |
| [6] | FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong. Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184. |
| [7] | ZHANG Jian, FANG Huihua. Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189. |
| [8] | WANG Shan, XIE Bo, LIU Huimin, LI Zhihao. Adverse event signals for celecoxib based on FAERS database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 190-194. |
| [9] | LI Yingfen, HAN Lei. Analysis of 319 cases of adverse drug reaction induced by cerebroprotein hydrolysate for injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 195-198. |
| [10] | XU Weijia, PENG Qi, HUANG Haiyu, ZHANG Leijiao, XIAO Hua, WU Xue. 285 cases of adverse drug reaction related to new antineoplastic drugs [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 199-203. |
| [11] | GUO Qinghua, PENG Xiaoxiao, ZHU Ping, LIU Xilin, YANG Yinghua, CHEN Zhihai. One case of multiple organ dysfunction syndrome caused by amlodipine overdose [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 204-207. |
| [12] | FANG Meilin, ZHENG Huimin, WANG Cunze, WANG Ling, RUAN Junshan. One case of generalized myalgia caused by oxaliplatin [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 208-210. |
| [13] | LI Na, GUO Jun, GUO Wenjia, LYU Yinyin, LI Caihong, MU Xiangdong. One case of delayed skin allergic reaction caused by asthma treated with omalizumab injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 211-212. |
| [14] | CAO Guiping, DENG Linlin, ZHU Ganhong, LU Ying, MA Shuang, CHEN Linlin, Liu Lili. One case of severe liver injury caused by Tianma Shouwu tablets [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 216-218. |
| [15] | ZHU Ying, SHEN Lu, LI Lan, WU Jianmin, GAO Xiaojie. Adverse reaction monitoring of toothpaste in China under the new regulatory system [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 219-222. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
